Pharming Group N.V. (AMS: PHARM)
Netherlands
· Delayed Price · Currency is EUR
0.881
+0.025 (2.86%)
Dec 20, 2024, 5:35 PM CET
Pharming Group Revenue
Pharming Group had revenue of $74.85M USD in the quarter ending September 30, 2024, with 12.22% growth. This brings the company's revenue in the last twelve months to $285.75M, up 30.64% year-over-year. In the year 2023, Pharming Group had annual revenue of $245.32M with 19.30% growth.
Revenue (ttm)
$285.75M
Revenue Growth
+30.64%
P/S Ratio
2.24
Revenue / Employee
$748.02K
Employees
382
Market Cap
597.29M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 245.32M | 39.69M | 19.30% |
Dec 31, 2022 | 205.62M | 6.75M | 3.39% |
Dec 31, 2021 | 198.87M | -13.30M | -6.27% |
Dec 31, 2020 | 212.17M | 22.79M | 12.03% |
Jan 1, 2020 | 189.39M | 54.26M | 40.15% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Galapagos NV | 260.09M |
ASML Holding N.V. | 26.24B |
Unilever PLC | 60.29B |
Prosus N.V. | 5.27B |
RELX PLC | 10.97B |
ING Groep N.V. | 17.21B |
Pharming Group News
- 6 days ago - Pharming Group offers to buy Sweden's Abliva for SEK 0.45/shr - Seeking Alpha
- 6 days ago - Pharming announces public cash offer to the shareholders of Abliva AB - GlobeNewsWire
- 10 days ago - European Biotech Pharming Group Touts Positive Data From Pivotal Pediatric Study Of FDA-Approved Immune System Disorder Drug - Benzinga
- 10 days ago - European Biotech Pharming Group Touts Positive Data From Pivotal Pediatric Study Of FDA-Approved Immune System Disorder Drug - Benzinga
- 6 weeks ago - Morgan Stanley's Strategic Acquisition of Pharming Group Shares - GuruFocus
- 6 weeks ago - Pharming Group to participate in November investor conference - GlobeNewsWire
- 2 months ago - Pharming Group N.V. (PHAR) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Pharming Group N.V. 2024 Q3 - Results - Earnings Call Presentation - Seeking Alpha